Earnings Working Against Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Share Price
Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) price-to-earnings (or “P/E”) ratio of 7.6x might make it look like a strong buy right now compared to the market in the United States, where around half of the companies have P/E ratios above 19x and even P/E’s above 33x are quite common. However, the P/E might be quite low for a reason and it requires further investigation to determine if it’s justified.
Amphastar Pharmaceuticals could be doing better as its earnings have been going backwards lately while most other companies have been seeing positive earnings growth. It seems that many are expecting the dour earnings…
